FibroBiologics, Inc. Common Stock (FBLG)
FBLG Stock Price Chart
Explore FibroBiologics, Inc. Common Stock interactive price chart. Choose custom timeframes to analyze FBLG price movements and trends.
FBLG Company Profile
Discover essential business fundamentals and corporate details for FibroBiologics, Inc. Common Stock (FBLG) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Feb 2024
Employees
13.00
Website
https://www.fibrobiologics.comCEO
Peter O'Heeron
Description
FibroBiologics, Inc. operates as a clinical-stage biopharmaceutical firm, advancing therapies derived from fibroblasts toward commercialization within the United States. The company's pipeline includes CybroCell, currently being developed to address degenerative disc disease; CYMS101, targeting multiple sclerosis; and CYWC628 for wound repair. Further demonstrating its broad scope, early-stage investigations are underway for CYTER915, aimed at restoring or enhancing thymus and/or spleen function; CYPS317, for psoriasis; and TCB190, designed to combat specific cancers. FibroBiologics was founded in 2021 and is situated in Houston, Texas.
FBLG Financial Timeline
Browse a chronological timeline of FibroBiologics, Inc. Common Stock corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Jul 2026
EPS estimate is -$0.93.
Earnings released on 30 Apr 2026
EPS came in at -$1.33 falling short of the estimated -$1.26 by -5.56%.
Stock split effective on 30 Mar 2026
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 24 Feb 2026
EPS came in at -$0.98 surpassing the estimated -$1.44 by +31.94%.
Earnings released on 31 Oct 2025
EPS came in at -$0.13 falling short of the estimated -$0.10 by -30.00%.
Earnings released on 31 Jul 2025
EPS came in at -$0.12 falling short of the estimated -$0.11 by -9.09%.
Earnings released on 31 Mar 2025
EPS came in at -$0.09 surpassing the estimated -$0.10 by +10.00%.
Earnings released on 27 Mar 2025
EPS came in at -$0.09 surpassing the estimated -$0.10 by +5.73%.
Earnings released on 12 Nov 2024
EPS came in at -$0.08 matching the estimated -$0.08.
Earnings released on 7 Aug 2024
EPS came in at -$0.09 matching the estimated -$0.09.
Earnings released on 14 May 2024
EPS came in at -$0.27 .
Earnings released on 31 Dec 2023
EPS came in at -$0.34 .
Earnings released on 30 Sept 2023
EPS came in at -$0.07 .
Earnings released on 30 Jun 2023
EPS came in at -$0.07 .
Earnings released on 31 Mar 2023
EPS came in at -$0.07 .
Earnings released on 31 Dec 2022
EPS came in at -$0.05 .
Earnings released on 29 Sept 2022
EPS came in at -$0.05 .
Earnings released on 30 Jun 2022
EPS came in at -$0.04 .
Earnings released on 31 Mar 2022
EPS came in at -$0.04 .
FBLG Stock Performance
Access detailed FBLG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
